Send feedback

ATP7B p.His1069Gln

c.3207C>A · rs76151636 · VCV3848

Pathogenic Multiple submitters
Classification
Pathogenic
ClinVar
Review
Multiple submitters ★★☆☆
ClinVar · 47 submitters
AlphaMissense
likely pathogenic
0.9933 · ACMG-weighted
gnomAD v4.1
Rare
rare (popmax 0.106%, nfe)
Missense predictors
3/3 damaging
AlphaMissense, REVEL, SaProt
Conditions
2
ATP7B-related disorder

Computational evidence

Protein change
AlphaMissense0.9933likely pathogenic ✓ concordant with ClinVar · top 3% in ATP7B
REVEL0.909moderately pathogenic-leaning
SaProtLLR -15.40damaging
⇒ AlphaMissense, REVEL and SaProt all call this damaging.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 3.3GERP -0.95, phastCons 1
Regional constrainto/e 1.00unconstrained · MANE · 77 kb · p 0.92 · regional, not allelic
Overall
CADD22.8PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.106% European (non-Finnish) · 1,249/1,180,030 alleles
Filtering AF 0.101% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.099%
Overall 0.0944% 1,523/1,614,166 alleles · rare
Ancestry group Frequency 1 in
Ashkenazi Jewishnot grpmax-eligible 0.527% 190
European (non-Finnish)grpmax 0.106% 945
Remaining individualsnot grpmax-eligible 0.0928% 1,078
Finnishnot grpmax-eligible 0.05% 2,001
Admixed American 0.0417% 2,401
African / African-American 0.004% 25,015

Ashkenazi Jewish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
ATP7B
Protein
p.His1069Gln
Coding
c.3207C>A
MANE Select
NM_000053
dbSNP
rs76151636
Type
single nucleotide variant
Location
chr13:51944145 (GRCh38)
Gene constraint
LOEUF 1.063 · pLI <0.01 · ClinGen HI gene assoc. with recessive phenotype (gnomAD)
Structure
AlphaFold pLDDT 71.83 · 13 PDB
Residue 1069
a UniProt-annotated variant site (in wd; common mutation; decreased copper transport activity; loss of atpase activity; cannot form an acylphosphate intermediate during catalysis; does not alter the folding of the nucleotide-binding domain; decreased stability; does not localize to late endosomes)
Full ATP7B gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

ATP7B-related disorder

Also linked: Wilson disease

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/atp7b-p-his1069gln (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown